The global chemotherapy devices market is was valued at 152.80 million USD in 2017 and is anticipated to grow at a significant rate during the forecast period. Chemotherapy devices are used to slow down or kill the growth of cancer cells. The drugs generally used are called cytotoxics and are often obtained from natural sources like plats or are otherwise devised in a typical clinical laboratory.

Download Free Sample Report @

Targeted therapy has gained market traction over the past decade owing to its effectiveness in destroying the specific cancer cells, without adversely affecting the nearby healthy tissues or organs. It is often used in combination with chemotherapy and the drugs used in target therapy can be used together with or instead of chemotherapy. This therapy uses drugs that works differently than chemo drugs. While the later affects all rapidly dividing cells and works by killing cytotoxic cells, targeted therapy targets molecules within cells and often blocks cell growth (cytostatic).

The market is primarily driven by the rising occurrence of cancer like sarcoma, lymphoma, lung cancer, myeloma, and breast cancer. Cancer is the second most prevailing cause of deaths globally and according to the American Cancer Society; 1.7 million new cancer cases were determined in the year 2019. Therefore, rising cancer prevalence is fueling the adoption of chemotherapy devices and other cancer treatment options, which in turn is boosting market growth.

The rising focus on research and development of various cancer therapeutic drugs fore precise biological drug therapies is propelling the demand for the market. The government and non-government organizations are undertaking various initiatives for raising funds to support R&D activities, foster the adoption of advanced technologies, and create necessary cancer awareness.

However, reluctance showed by patients to undergo chemotherapy, concerns regarding infections, the fear of undergoing invasive treatment procedures, and the absence of insurance and reimbursement policies across developing countries is anticipated to limit this market globally. However, a CVAD device does not cause a lot of pain, redness, discomfort, or swelling.

Browse Full Research Report with TOC @

Radiant Insights, Inc. data shows that North America is the biggest contributor to the Chemotherapy Devices revenue market, accounted for 41.27% of the total global market with a revenue of 63.06 million USD in 2017, followed by Europe, 39.07% with a revenue of 59.71 million USD.

Becton, Dickinson is the largest company in the global Chemotherapy Devices market, accounted for 16.50% of the revenue market share in 2017, followed by ICU Medical and Terumo Corporation, accounted for 12.63% and 11.81% of the revenue market share in 2017. The Chemotherapy Devices industry is not concentrated, these manufacturers range from large multinational corporations to small privately owned companies compete in this industry. The top ten manufacturers account for 82.72% of the revenue market.

This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering

• Becton, Dickinson
• ICU Medical
• Terumo Corporation
• B. Braun
• Halyard Health
• Smiths Group
• Baxter International
• Fresenius
• Moog
• Zyno Medical
• Micrel Medical

On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into

• LVP (Large Volume Pump)
• Syringe Pump
• Elastomeric Pumps

By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into

• Hospital & Clinic
• Home Care

By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like

• China
• Europe
• Japan
• Korea
• India
• Southeast Asia
• South America


Read all Reports of this category @

About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll-Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: [email protected]